| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |